Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Virtual Reality for Pain Management in Burn Patients

Not Applicable

Recruiting

Conditions: Pain

Interventions: Other: Virtual Reality

First Posted Date: 2020-12-28

Last Posted Date: 2024-08-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT04685486

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

Phase 2

Recruiting

Conditions: Chronic Lymphocytic Leukemia
Richter Syndrome

Interventions: Drug: Polatuzumab Vedotin
Drug: Rituximab
Drug: Etoposide
Drug: Prednisone
Drug: Cyclophosphamide
Drug: Hydroxydaunomycin

First Posted Date: 2020-12-22

Last Posted Date: 2024-10-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04679012

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Mount Sinai- Icahn School of Medicine, New York, New York, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

and more 1 locations

Telehealth Language Intervention for Children With Autism Ages 2-4 Years

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Toy Talk

First Posted Date: 2020-12-19

Last Posted Date: 2022-08-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 14

Registration Number: NCT04675580

Locations: 🇺🇸
Center for Autism and the Developing Brain/New York-Presbyterian Hospital, White Plains, New York, United States

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Phase 1

Recruiting

Conditions: Pseudomonas Aeruginosa
Hematologic Malignancy
Pneumonia

Interventions: Drug: Ceftolozane / Tazobactam Injection

First Posted Date: 2020-12-17

Last Posted Date: 2024-08-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04673175

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients

Not Applicable

Completed

Conditions: Ulcerative Colitis (UC)
Indeterminate Colitis
Crohn Disease (CD)

Interventions: Other: Vaccine Education

First Posted Date: 2020-12-17

Last Posted Date: 2023-07-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT04672161

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Early Intervention With Acalabrutinib in Patients With High Risk CLL

Phase 2

Withdrawn

Conditions: Chronic Lymphocytic Leukemia
CLL/SLL

Interventions: Drug: Acalabrutinib

First Posted Date: 2020-12-09

Last Posted Date: 2022-04-05

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04660045

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: Cabozantinib

First Posted Date: 2020-11-17

Last Posted Date: 2024-07-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 30

Registration Number: NCT04631744

Locations: 🇺🇸
New Jersey Urology/Summit Medical Group, Saddle Brook, New Jersey, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

and more 2 locations

Rimegepant in Moderate Plaque-type Psoriasis

Phase 2

Active, not recruiting

Conditions: Psoriasis

Interventions: Drug: Rimegepant
Drug: Placebo

First Posted Date: 2020-11-16

Last Posted Date: 2024-11-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 41

Registration Number: NCT04629950

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Sadick Dermatology, New York, New York, United States

Chronic Pain Diagnosis and Treatment in Torture Survivors

Not Applicable

Recruiting

Conditions: Pain
Pain, Chronic

Interventions: Other: Pain Evaluation and BPISF
Other: Surveys, a fingerstick blood sample, EMAs, and a digital wearable device

First Posted Date: 2020-11-16

Last Posted Date: 2024-08-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 100

Registration Number: NCT04629963

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Mount Sinai Human Rights Program, New York, New York, United States
🇺🇸
Columbia University Human Rights Initiative and Asylum Clinic, New York, New York, United States

and more 1 locations

General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19

Not Applicable

Recruiting

Conditions: Moral Injury
Post-traumatic Stress Disorder

Interventions: Behavioral: Medical Music
Behavioral: Prolonged Exposure Therapy
Behavioral: Narrative Writing
Behavioral: Interpersonal Psychotherapy

First Posted Date: 2020-11-12

Last Posted Date: 2024-08-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 120

Registration Number: NCT04626050

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy